Login / Signup

Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy - Analysis from the UK Medical Cannabis Registry.

Simon ErridgeCarl HolveyRoss CoomberJonathan HoareShaheen KhanMichael W PlattJames J RuckerMark W WeatherallSushil BeriMikael H Sodergren
Published in: Neuropediatrics (2023)
 The results of this study demonstrate a positive signal of improved seizure frequency in children treated with Cannabis-based medicinal products (CBMPs) for TRE. Moreover, the results suggest that CBMPs are well-tolerated in the short term. The limitations mean causation cannot be determined in this open-label, case series.
Keyphrases
  • open label
  • young adults
  • healthcare
  • clinical trial
  • squamous cell carcinoma
  • big data
  • newly diagnosed
  • phase ii
  • artificial intelligence
  • phase ii study
  • temporal lobe epilepsy